US drug sales continue to riseBMJ 2003; 326 doi: https://doi.org/10.1136/bmj.326.7388.518/c (Published 01 March 2003) Cite this as: BMJ 2003;326:518
- Scott Gottlieb
- New York
Despite continuing pricing pressures and competition from generic drugs, total US pharmaceutical sales grew 12% last year to $220bn (£140bn; ‡202bn), according to new data.
The pace of growth in US sales of prescription products slowed in 2002, compared with the 18% increase in 2001, according to the PharmaTrends 2002 report, released by healthcare tracking firm NDC Health.
The top five classes of drug remained in the same position as in 2001. Cholesterol …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial